Toxic Epidermal Necrolysis Associated with Gemcitabine Therapy in a Patient with Metastatic Transitional Cell Carcinoma of the Bladder

Journal of Chemotherapy

Volumn 15, Issue 5, 2003, Pages 510-511

  Mermershtain, W ^a   Cohen, A D ^a   Lazarev, I ^a   Grunwald, M ^a   Ariad, S ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Gemcitabine; Toxic epidermal necrolysis; Transitional cell carcinoma

Indexed keywords

GEMCITABINE;

AGED; ARTICLE; BLADDER CARCINOMA; CASE REPORT; ERYTHEMA; FATALITY; FEVER; HUMAN; METASTASIS; RASH; TOXIC EPIDERMAL NECROLYSIS; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

EID: 0142154945     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2003.15.5.510     Document Type: Article

References (11)

1. Tonato M., Mosconi AM, Martin C. Safety profile of gemcitabine. Anticancer Drugs 1995; 6 (suppl 6): 27-32.
2. Burstein HJ Radiation recall dermatitis from gemcitabine. J Clin Oncol 2000; 18 (3):693-694.
3. Castellano D, Hitt R, Cortes-Funes H, Romero A, Rodriguez-Peralto JL. Radiation recall reaction induced by gemcitabine. J Clin Oncol 2000; 18(3): 695-696.
4. Bar-Sela G, Beny A, Bergman R, Kuten A. Gemcitabine-induced radiation recall dermatitis: case report. Tumori 2001; 87(6): 428-430.
5. Jeter MD, Jane PA, Brooks S, Burstein HJ, Wen P, Fuchs CS, et al. Int J Radiat Oncol Biol Phys 2002; 53(2): 394-400.
6. Brandes A, Reichmann U, Plasswilm L, Bamverg M. Time-and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine - a report of three cases. Anticancer Drugs 2000; 11(1): 15-17.
7. del Pozo J, Martinez W, Yebra-Pimentel MT, Almagro M, Pena-Penabad C, Fonseca E. Linear immunogolobulin A bullous dermatosis induced by gemcitabine. Ann Pharmacother 2001; 35(7): 891-893.
8. Kuku I, Kaya E, Sevinc A, Aydogdu I. Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesotelioma. J Eur Acad Dermatol Venerol 2002; 16(3): 271-272.
9. Fritsch PO, Sidoroff A. Drug-induced Stevens-Johnson syndrome / toxic epidermal necrolysis. Am J Clin Dermatol 2000; 1(16): 349-360.
10. Wolkenstein P, Revuz J. Toxic epidermal necrolysis. Dermatol Clin 2000; 18(3): 485-495.
11. Schulz JT, Sheridan RL, Ryan CM, MacKool B, Tompkins RG. A 10-year experience with toxic epidermal necrolysis. J Burn Care Rehabil 2000; 21(3):199-204.